Gene · 1595
Papers2,112
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,112
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Surfactin and Capric Acid Affect the Posaconazole Susceptibility of Candida albicans Strains with Altered Sterols and Sphingolipids Biosynthesis. | Int J Mol Sci | 2023 | 38139328 | PubTator, text mining | PubMed |
| Role of the Mitochondrial E3 Ubiquitin Ligases as Possible Therapeutic Targets in Cancer Therapy. | Int J Mol Sci | 2023 | 38139010 | PubTator, text mining | PubMed |
| Heterozygous Knockout of ARID4B Using CRISPR/Cas9 Attenuates Some Aggressive Phenotypes in a Breast Cancer Cell Line. | Genes (Basel) | 2023 | 38137006 | PubTator, text mining | PubMed |
| Lipid-Centric Approaches in Combating Infectious Diseases: Antibacterials, Antifungals and Antivirals with Lipid-Associated Mechanisms of Action. | Antibiotics (Basel) | 2023 | 38136750 | PubTator, text mining | PubMed |
| Exploring Novel Variants of the Cytochrome P450 Reductase Gene (POR) from the Genome Aggregation Database by Integrating Bioinformatic Tools and Functional Assays. | Biomolecules | 2023 | 38136599 | PubTator, text mining | PubMed |
| Dose-Dependent Genetic Resistance to Azole Fungicides Found in the Apple Scab Pathogen. | J Fungi (Basel) | 2023 | 38132737 | PubTator, text mining | PubMed |
| New Frontiers in Acanthamoeba Keratitis Diagnosis and Management. | Biology (Basel) | 2023 | 38132315 | PubTator, text mining | PubMed |
| p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells. | Cell Death Dis | 2023 | 38123597 | PubTator, text mining | PubMed |
| Hepatotoxicity Induced by Azole Antifungal Agents: A Review Study. | Iran J Pharm Res | 2023 | 38116543 | PubTator, text mining | PubMed |
| Therapeutic Updates on the Management of Tinea Corporis or Cruris in the Era of Trichophyton Indotineae: Separating Evidence from Hype-A Narrative Review. | Indian J Dermatol | 2023 | 38099117 | PubTator, text mining | PubMed |
| Short-course combination treatment for experimental chronic Chagas disease. | Sci Transl Med | 2023 | 38091410 | PubTator, text mining | PubMed |
| UBE3C Facilitates the ER-Associated and Peripheral Degradation of Misfolded CFTR. | Cells | 2023 | 38067172 | PubTator, text mining | PubMed |
| Galectins in Protozoan Parasitic Diseases: Potential Applications in Diagnostics and Therapeutics. | Cells | 2023 | 38067100 | PubTator, text mining | PubMed |
| Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review. | Front Pharmacol | 2023 | 38034996 | PubTator, text mining | PubMed |
| Left atrial expansion index measured with cardiovascular magnetic resonance estimates pulmonary capillary wedge pressure in dilated cardiomyopathy. | J Cardiovasc Magn Reson | 2023 | 38031092 | PubTator, text mining | PubMed |
| Whole genome analysis of Rhizopus species causing rhino-cerebral mucormycosis during the COVID-19 pandemic. | Front Cell Infect Microbiol | 2023 | 38029246 | PubTator, text mining | PubMed |
| CLICK-chemoproteomics and molecular dynamics simulation reveals pregnenolone targets and their binding conformations in Th2 cells. | Front Immunol | 2023 | 38022565 | PubTator, text mining | PubMed |
| New Steroidal Selenides as Proapoptotic Factors. | Molecules | 2023 | 38005248 | PubTator, text mining | PubMed |
| The Microevolution of Antifungal Drug Resistance in Pathogenic Fungi. | Microorganisms | 2023 | 38004768 | PubTator, text mining | PubMed |
| Essential Role of Granulosa Cell Glucose and Lipid Metabolism on Oocytes and the Potential Metabolic Imbalance in Polycystic Ovary Syndrome. | Int J Mol Sci | 2023 | 38003436 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1595/papers?page=9